Anticoagulation in patients with atrial fibrillation. Not safe and not cheap.
作者信息
Rassam S M
出版信息
BMJ. 1993 Dec 4;307(6917):1492. doi: 10.1136/bmj.307.6917.1492.
Abstract
摘要
相似文献
1
Anticoagulation in patients with atrial fibrillation. Not safe and not cheap.心房颤动患者的抗凝治疗。既不安全也不便宜。
BMJ. 1993 Dec 4;307(6917):1492. doi: 10.1136/bmj.307.6917.1492.
2
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation.心房颤动患者的抗凝治疗。全科医生未做好抗凝监测的准备。
BMJ. 1993 Dec 4;307(6917):1493. doi: 10.1136/bmj.307.6917.1493.
3
Anticoagulation in patients with atrial fibrillation. Atrial fibrillation associated with aging.心房颤动患者的抗凝治疗。心房颤动与衰老相关。
BMJ. 1993 Dec 4;307(6917):1494. doi: 10.1136/bmj.307.6917.1494-a.
4
Anticoagulation in patients with atrial fibrillation. Don't deny treatment to elderly people.心房颤动患者的抗凝治疗。不要拒绝为老年人提供治疗。
BMJ. 1993 Dec 4;307(6917):1493-4. doi: 10.1136/bmj.307.6917.1493-c.
5
Anticoagulation in patients with atrial fibrillation. Use of warfarin dependent on local services.心房颤动患者的抗凝治疗。华法林的使用取决于当地医疗服务情况。
BMJ. 1993 Dec 4;307(6917):1493. doi: 10.1136/bmj.307.6917.1493-b.
6
Stroke prevention in non-rheumatic atrial fibrillation.
Tenn Med. 1997 Jan;90(1):21-2.
7
Anticoagulation in patients with atrial fibrillation. Doctors reluctant despite evidence.心房颤动患者的抗凝治疗。尽管有证据，但医生仍不情愿。
BMJ. 1993 Dec 4;307(6917):1494. doi: 10.1136/bmj.307.6917.1494.
8
Stroke prevention in atrial fibrillation.
BMJ. 1997 May 31;314(7094):1563-4. doi: 10.1136/bmj.314.7094.1563.
9
10
Anticoagulation update.抗凝治疗最新进展。
S D J Med. 1994 Jul;47(7):233-4.
引用本文的文献
1
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.华法林在非风湿性心房颤动中的应用：来自全科医疗的评论
Br J Gen Pract. 1995 Mar;45(392):153-8.
本文引用的文献
1
Survey of use of anticoagulation in patients with atrial fibrillation.心房颤动患者抗凝治疗使用情况调查。
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
2
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.华法林与阿司匹林预防慢性心房颤动血栓栓塞并发症的安慰剂对照随机试验。哥本哈根AFASAK研究。
Lancet. 1989 Jan 28;1(8631):175-9. doi: 10.1016/s0140-6736(89)91200-2.
3
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.心房颤动作为卒中的独立危险因素：弗雷明汉姆研究
Stroke. 1991 Aug;22(8):983-8. doi: 10.1161/01.str.22.8.983.
4
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.加拿大房颤抗凝（CAFA）研究
J Am Coll Cardiol. 1991 Aug;18(2):349-55. doi: 10.1016/0735-1097(91)90585-w.
5
Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project).心房颤动与中风：不同类型中风中的患病率及其对早期和长期预后的影响（牛津郡社区中风项目）
BMJ. 1992 Dec 12;305(6867):1460-5. doi: 10.1136/bmj.305.6867.1460.
6
Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.心房颤动一级预防的成本效益：瑞典国家视角
BMJ. 1992 Dec 12;305(6867):1457-60. doi: 10.1136/bmj.305.6867.1457.
7
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.华法林用于预防非风湿性心房颤动相关的中风。退伍军人事务部非风湿性心房颤动中风预防研究人员。
N Engl J Med. 1992 Nov 12;327(20):1406-12. doi: 10.1056/NEJM199211123272002.
Zotero 插件